Mannatech (NASDAQ:MTEX) Share Price Passes Below 200-Day Moving Average of $11.62

Mannatech, Incorporated (NASDAQ:MTEXGet Free Report) shares crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $11.62 and traded as low as $8.45. Mannatech shares last traded at $8.55, with a volume of 1,142 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Mannatech in a report on Thursday. They issued a “buy” rating for the company.

Get Our Latest Report on Mannatech

Mannatech Stock Up 1.1 %

The company has a debt-to-equity ratio of 0.10, a current ratio of 1.09 and a quick ratio of 0.50. The business’s fifty day simple moving average is $9.91 and its two-hundred day simple moving average is $11.62. The company has a market cap of $15.90 million, a PE ratio of -2.12 and a beta of 1.20.

Mannatech (NASDAQ:MTEXGet Free Report) last released its quarterly earnings data on Tuesday, November 7th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $32.55 million during the quarter. Mannatech had a negative net margin of 5.62% and a negative return on equity of 59.58%.

Institutional Trading of Mannatech

An institutional investor recently raised its position in Mannatech stock. Tower Research Capital LLC TRC lifted its stake in shares of Mannatech, Incorporated (NASDAQ:MTEXFree Report) by 167.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,575 shares of the company’s stock after purchasing an additional 987 shares during the period. Tower Research Capital LLC TRC owned about 0.08% of Mannatech worth $27,000 as of its most recent filing with the Securities & Exchange Commission. 24.31% of the stock is currently owned by institutional investors.

Mannatech Company Profile

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.

Read More

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.